Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26FQJT8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,589
Award facts
- Contract value 100% obligated
- $10,588.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on November 12, 2025, with completion scheduled by December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy supporting the Department of Defense's pharmaceutical supply needs.
DMS Pharmaceutical Group operates as a critical regional prime vendor contractor under the PPV-G GEN V program, authorized to supply a comprehensive range of branded and generic prescription medications, biologics, and medical consumables to military healthcare facilities worldwide. The company's single-award indefinite delivery contract, valued at $499,999,999 with a completion date of December 31, 2036, encompasses a 30-month base period with three 30-month option periods. This delivery order for Nuplazid exemplifies DMS Pharmaceutical Group's role in fulfilling specialized pharmaceutical requirements across the Department of Defense's global medical supply chain, with the company demonstrating consistent performance through numerous prior awards from the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FQJT8?
SPE2DR26FQJT8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FQJT8 worth?
The government has obligated $10,589 on SPE2DR26FQJT8.
Is contract SPE2DR26FQJT8 an order under another contract?
Yes. SPE2DR26FQJT8 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJT8 competed?
The extent of competition for SPE2DR26FQJT8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award